McAdam LLC’s Ambev ABEV Stock Holding History

McAdam LLC’s Portfolio ABEV Stock Details ABEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-880	Closed	-$4K	–	66
2018 Q3	$4K	Hold	880	–	–	﹤0.01%	429
2018 Q2	$4K	Hold	880	–	–	﹤0.01%	413
2018 Q1	$6K	Buy	+880	New	+$6.05K	﹤0.01%	376

Other funds holding ABEV

VAM

Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Harding Loevner Bridgewater, New Jersey $10.6B AUM 19.39% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

McAdam LLC's ABEV Position: Q4 2018 in Review

McAdam LLC sold out of Ambev (ABEV) in Q4 2018, closing a stake of 880 shares — an estimated $4K sold.

McAdam LLC first reported a position in ABEV in Q1 2018 and held it in 3 quarters. The position peaked at $6K in Q1 2018. 318 funds tracked by Wall St. Rank hold ABEV as of Q4 2018.

McAdam LLC reported no remaining Ambev position as of Q4 2018 after selling out during the quarter.
McAdam LLC sold 880 Ambev shares in Q4 2018, an estimated $4K.
McAdam LLC first reported a position in Ambev in Q1 2018 and held it in 3 quarters.
McAdam LLC's Ambev position peaked at $6K in Q1 2018.
318 funds tracked by Wall St. Rank held Ambev as of Q4 2018.

Based on McAdam LLC's 13F filing for Q4 2018, filed 30 Jan 2019.